Earkart Limited vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Earkart Limited is ₹ 119.1 as of 23 Oct 15:30 . The P/E Ratio of Earkart Limited changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Earkart Limited changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 25.38 crore on March 2025 . This represents a CAGR of -6.06% over 5 years The revenue of Earkart Limited for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Earkart Limited for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Earkart Limited changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Earkart Limited changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Earkart Limited

Earkart Limited was originally formed as a Private Limited Company in the name and style of 'Earkart Private Limited' on April 14, 2021 vide Certificate of Incorporation issued by Registrar of Companies, Kanpur.
On October 11, 2021, Rohit Misra acquired a majority of the equity shares from them and became the Promoter of the Company.
Thereafter, the status of the Company was taken public and the name was changed to 'Earkart Limited' dated December 18, 2024 by the Registrar of Companies, Central Processing Centre. Company manufacture and distribute modern hearing aids and related accessories at affordable price across India.
Along with the own manufactured hearing aid, it also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.
In addition, it offer other products like adjustable foldable walkers and MultiSensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Earkart Limited and Transgene Biotek Ltd

Which company has a larger market capitalization, Earkart Limited or Transgene Biotek Ltd?

Market cap of Earkart Limited is 163 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Earkart Limited and Transgene Biotek Ltd?

The stock performance of Earkart Limited and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Earkart Limited and Transgene Biotek Ltd?

As of October 25, 2026, the Earkart Limited stock price is INR ₹119.1. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Earkart Limited and Transgene Biotek Ltd compare?

To compare the dividend payouts of Earkart Limited and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.